SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-078796
Filing Date
2020-06-30
Accepted
2020-06-30 13:57:12
Documents
1
Period of Report
2020-06-26

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 8989
  Complete submission text file 0001104659-20-078796.txt   10427
Mailing Address 1040 SPRING ST SILVER SPRING MD 20910
Business Address 1040 SPRING ST SILVER SPRING MD 20910 3016089292
UNITED THERAPEUTICS Corp (Issuer) CIK: 0001082554 (see all company filings)

IRS No.: 521984749 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O UNITED THERAPEUTICS CORPORTION 1735 CONNECTICUT AVE. NW WASHINGTON DC 20009
Business Address
Giltner Richard (Reporting) CIK: 0001460472 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26301 | Film No.: 201001886